drugset / Trial / NCT01179412

Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine

NCT01179412

Phase 4 Completed 172 enrolled Mahidol University
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the outcomes of treating epidemic keratoconjunctivitis with 2% povidone-iodine.

Timeline

Start
2004-07
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Povidone-Iodine Other / unclassified 2 %

Indications